News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Seltzer Stacey Denenberg
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Seltzer Stacey Denenberg (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $9.01, valued at
$157.7k
|
|
| 06/03/2022 |
4
| Seltzer Stacey Denenberg (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $2.09, valued at
$36.6k
|
|
| 04/12/2021 |
4
| Seltzer Stacey Denenberg (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 14,000 options to buy
@ $15, valued at
$210k
|
|
| 10/14/2020 |
4
| Seltzer Stacey Denenberg (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Unknown transaction of 10,221 shares
@ $34.5, valued at
$352.6k
Disposed/sold 7,840 shares
@ $34.5, valued at
$270.5k
Disposed/sold 52,421 options to buy
@ $6.29, valued at
$329.7k
Disposed/sold 19,755 options to buy
@ $15.4, valued at
$304.2k
Disposed/sold 17,500 options to buy
@ $18.26, valued at
$319.6k
Disposed/sold 7,500 options to buy
@ $32.79, valued at
$245.9k
Disposed/sold 11,432 options to buy
@ $19.9, valued at
$227.5k
Disposed/sold 15,398 options to buy
@ $17.11, valued at
$263.5k
|
|
| 05/29/2020 |
4
| Seltzer Stacey Denenberg (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Granted 7,840 shares
@ $0
Granted 15,398 options to buy
@ $17.11, valued at
$263.5k
|
|
| 05/28/2019 |
4
| Seltzer Stacey Denenberg (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Granted 6,442 shares
@ $0
Granted 11,432 options to buy
@ $19.9, valued at
$227.5k
|
|
| 05/24/2018 |
4
| Seltzer Stacey Denenberg (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Granted 3,750 shares
@ $0
Granted 7,500 options to buy
@ $32.79, valued at
$245.9k
|
|
| 12/08/2017 |
4
| Seltzer Stacey Denenberg (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Acquired 29 shares
@ $0 |
|
| 05/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/27/2016 |
4
| Seltzer Stacey Denenberg (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Granted 19,755 options to buy
@ $15.4, valued at
$304.2k
|
|
|
|